gefitinib has been researched along with Infarction, Middle Cerebral Artery in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, H; Chen, X; Shen, J; Wang, Q; Wu, H; Xie, XJ | 1 |
1 other study(ies) available for gefitinib and Infarction, Middle Cerebral Artery
Article | Year |
---|---|
Astragaloside VI Promotes Neural Stem Cell Proliferation and Enhances Neurological Function Recovery in Transient Cerebral Ischemic Injury via Activating EGFR/MAPK Signaling Cascades.
Topics: Animals; Astrocytes; Brain Ischemia; Cell Differentiation; Cell Proliferation; Cells, Cultured; Epidermal Growth Factor; ErbB Receptors; Flavonoids; Gefitinib; Infarction, Middle Cerebral Artery; Male; MAP Kinase Signaling System; Memory; Motor Activity; Neural Stem Cells; Neurogenesis; Rats, Sprague-Dawley; Recovery of Function; Saponins; Spheroids, Cellular; Triterpenes | 2019 |